Chemed Corp (NYSE:CHE)
| 508.55 BATS BZX Real-Time Price As of 10:47am ET |  -5.91 / -1.15%Today’s Change | 430.16 Today|||52-Week Range 574.66 | -0.37% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 110.3M | 108.7M | 98.2M | 205.5M | |
| Depreciation | 33.5M | 34.6M | 35.6M | 38.9M | ||
| Total Other Cash Flow | 29.5M | 30.6M | 39.3M | 19.7M | ||
| Funds From Operations | 179.6M | 167.3M | 175.6M | 269.3M | ||
| Funds From/For Other Operating Expenses | 8.1M | 31.9M | 13.1M | -17.9M | ||
| Net Cash Flow - Operating Activities | 171.5M | 135.4M | 162.5M | 287.1M | ||
| Investing | Capital Expenditures | -44.1M | -39.8M | -64.3M | -52.9M | |
| Net Assets From Acquisitions | -6.6M | 0.00 | -4.7M | -53.2M | ||
| Other Investing - Uses | -- | -90.0K | 0.00 | 0.00 | ||
| Other Investing - Sources | 432.0K | 0.00 | 1.4M | 824.0K | ||
| Net Cash Flow Investing | -50.3M | -39.9M | -67.6M | -105.2M | ||
| Financing | Short Term Borrowings | -50.0M | 0.00 | 0.00 | 0.00 | |
| Long Term Borrowings | 0.00 | 184.6M | 261.7M | 468.5M | ||
| Long Term Debt Reduction | -6.3M | -167.1M | -269.2M | -481.6M | ||
| Net Proceeds Stock Sale | 15.4M | 8.4M | 27.1M | 32.4M | ||
| Common Preferred Redeemed | -59.3M | -102.3M | -94.6M | -158.9M | ||
| Common Dividends | -15.6M | -16.4M | -17.4M | -18.7M | ||
| Cash Dividends Paid - Total | -15.6M | -16.4M | -17.4M | -18.7M | ||
| Other Sources - Financing | 14.0M | 7.4M | 7.6M | 0.00 | ||
| Other Uses - Financing | 18.9M | 9.5M | 14.2M | 30.0M | ||
| Net Cash Flow - Financing | -120.6M | -94.9M | -99.1M | -188.2M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 595.0K | 583.0K | -4.2M | -6.3M | ||
